Palo Alto Investors LP Iovance Biotherapeutics, Inc. Transaction History
Palo Alto Investors LP
- $501 Million
- Q1 2025
A detailed history of Palo Alto Investors LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 3,211,314 shares of IOVA stock, worth $5.59 Million. This represents 2.14% of its overall portfolio holdings.
Number of Shares
3,211,314
Previous 3,041,685
5.58%
Holding current value
$5.59 Million
Previous $22.5 Million
52.49%
% of portfolio
2.14%
Previous 3.6%
Shares
5 transactions
Others Institutions Holding IOVA
# of Institutions
334Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$48.3 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$42.5 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$36.9 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$22.1 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$19.2 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $275M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...